Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder
Trial details
- Registry ID
- NCT07116694
- Phase
- Phase 2
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as Dexmedetomidine
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar DisorderNCT07116694 | BioXcel Therapeutics Inc | Phase 2 | Completed | 2025-10-07Actual |
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |